Pregnancy appears difficult to obtain and TNF-α blockers cannot always be discontinued in women with rheumatic diseases

Clinical and Experimental Rheumatology

Volumn 27, Issue 6, 2009, Pages 1059-

  Gaujoux Viala, C ^a   Eymard, C ^a   Dougados, M ^a   Gossec, L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB;

ANKYLOSING SPONDYLITIS; CONCEPTION; DRUG EXPOSURE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MEDICAL RECORD REVIEW; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT WITHDRAWAL;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76649086335     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. MCLEOD C, BAGUST A, BOLAND A et al.: Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systemic review and economic evaluation. Health Technol Assess 2007; 11: 1-158.
2. GARTLEHNER G, HANSEN RA, JONAS B, THIEDA P, LOHR KN: The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: A systematic review and metaanalysis. J Rheumatol 2006; 33: 2398-408.
3. OESTENSEN M: New insights into sexual functioning and fertility in rheumatic disease. Best Pract Res Clin Rheumatol 2004; 18: 219-32.
4. FAUTREL B, BENHAMOU M: Rhumatisme inflammatoire chronique et procréation. Gynecol Obstet Fertil 2007; 35: 848-52.
5. KATZ JA, ANTONI C, KEENAN GF, SMITH DE, JACOBS SJ, LICHTENSTEIN GR: Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 2385-92.
6. HYRICH KL, WATSON KD, DIXON WG, SILMAN AJ, SYMMONS DPM: Pregnancy experience in women with rheumatic diseases exposed to biologic agents: results from the BSR biology register. Arthritis Rheum 2006; 54: 2701-2.
7. CHAMBERS CD, JOHNSON DL, JONES KL: Pregnancy outcome in women exposed to anti-TNF alpha medications: The OTIS rheumatoid arthritis in Pregnancy Study. Arthritis Rheum 2004; 50: S479.
8. CARTER JD, LADHANI A, RICCA LR, VALERIANO J, VASEY FB: A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009; 36: 635-41.